|
|
||||||||
The Journal of Immunology, Vol 138, Issue 12 4298-4302, Copyright © 1987 by American Association of Immunologists
ARTICLES |
VC Broudy, JM Harlan and JW Adamson
Tumor necrosis factor-alpha/cachectin (TNF-alpha) and tumor necrosis factor-beta/lymphotoxin (TNF-beta) are inflammatory mediators with similar spectrums of cytotoxic activity against tumors in vitro and in vivo. We compared the effect of purified recombinant human TNF-alpha and TNF-beta on neutrophil adhesion molecule expression and hematopoietic growth factor production by cultured human umbilical vein endothelial cells. Endothelial cells acquired adhesive properties for neutrophils after a 4-hr incubation with as little as 5 U/ml TNF-alpha. TNF-alpha stimulated a dose-dependent increase in endothelial cell adhesiveness for neutrophils, with a maximal effect at 250 U/ml. In contrast, TNF-beta did not enhance endothelial-dependent neutrophil adherence until a concentration of 600 to 1200 U/ml was reached. Endothelial cells cultured for 24 hr with TNF-alpha, 10 to 1,000 U/ml, released hematopoietic colony-stimulating activity. TNF-beta failed to augment growth factor production by endothelial cells at any concentration tested. Inhibitor assays showed that the absence of detectable colony-stimulating activity was not due to direct inhibition of colony growth by TNF-beta or to release of hematopoietic inhibitors by the TNF-beta-stimulated endothelial cells. Purified natural TNF-beta was similar to recombinant TNF-beta in its effect on neutrophil adhesion molecule expression and growth factor production by endothelial cells. These results indicate that the two immunomodulatory proteins TNF-alpha and TNF-beta differ in their effects on a common target tissue. TNF-beta, which retains tumoricidal properties, shows fewer proinflammatory activities on cultured endothelial cells than TNF- alpha in vitro.
This article has been cited by other articles:
![]() |
D. H. Petursdottir, I. Olafsdottir, and I. Hardardottir Dietary Fish Oil Increases Tumor Necrosis Factor Secretion but Decreases Interleukin-10 Secretion by Murine Peritoneal Macrophages J. Nutr., December 1, 2002; 132(12): 3740 - 3743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grell, H. Wajant, G. Zimmermann, and P. Scheurich The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor PNAS, January 20, 1998; 95(2): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. von Boehmer Lymphotoxins: From cytotoxicity to lymphoid organogenesis PNAS, August 19, 1997; 94(17): 8926 - 8927. [Full Text] [PDF] |
||||
![]() |
P De Togni, J Goellner, N. Ruddle, P. Streeter, A Fick, S Mariathasan, S. Smith, R Carlson, L. Shornick, J Strauss-Schoenberger, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin Science, April 29, 1994; 264(5159): 703 - 707. [Abstract] [PDF] |
||||
![]() |
L. E. Adams, K. Balakrishnan, S. M. Roberts, R. Belcher, A.-B. Mongey, T.J. Thomas, and E. V. Hess Genetic, Immunologic and Biotransformation Studies of Patients on Procainamide Lupus, April 1, 1993; 2(2): 89 - 98. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |